Submitted by Anonymous (not verified) on 13 March 2024 - 14:12
Opinion/decision on a Paediatric investigation plan (PIP): Alecensa, Alectinib, decision type: P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s), therapeutic area: Oncology, PIP number: P/0006/2022
Source: